Clinical Trials
2 trialsNCT04298606 2026-03-17
A Vaccine (CIMAvax-EGF) for the Prevention of Lung Cancer Development or Recurrence
Roswell Park Cancer Institute
Phase EARLY_PHASE1 Completed
NCT02748798 2024-10-15
Developing Optimal Parameters for Hyperpolarized Noble Gas and Inert Fluorinated Gas MRI of Lung Disorders
Thunder Bay Regional Health Research Institute
Phase EARLY_PHASE1 Terminated